Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

iTANK: a nuniversal technology to boost the efficacy of CAR T cell therapies by inducing dual mode-of-actio

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

An adjusted droplet digital PCR assay for quantification of vector copy number in CAR-T cell and TCR-T cell products (opens in new window)

Author(s): J. Ma, S. Meyer, J. Olweus, C. Jin, D. Yu
Published in: Immuno-Oncology and Technology, Issue 25, 2025, ISSN 2590-0188
Publisher: Elsevier BV
DOI: 10.1016/J.IOTECH.2024.101031

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas (opens in new window)

Author(s): Jing Ma, Tina Sarén, Chuan Jin, Hyeong Su Kim, Paola Donaji Contreras Pineda, Marina de Bernard, Rose-Marie Amini, Veronica Rondahl, Gunilla Enblad, Di Yu, Magnus Essand
Published in: Cancer Immunology, Immunotherapy, Issue 74, 2025, ISSN 1432-0851
Publisher: Springer Science and Business Media LLC
DOI: 10.1007/S00262-025-04112-1

CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers (opens in new window)

Author(s): Chuan Jin, Jing Ma, Mohanraj Ramachandran, Di Yu & Magnus Essand
Published in: Nature Biomedical Engineering, 2022, ISSN 2157-846X
Publisher: Nature publishing group
DOI: 10.1038/s41551-022-00875-5

Intellectual Property Rights

T-CELL IMMUNOTHERAPY

Application/Publication number: E P3512537A1
Date: 2023-11-01
Applicant(s): ELICERA THERAPEUTICS AB

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0